Group 1 - The core stock price of Wandong Medical (600055) closed at 16.97 yuan on January 9, 2026, with an increase of 2.04% and a trading volume of 82,000 shares, resulting in a total transaction amount of 139 million yuan [1] - On January 9, 2026, the net inflow of main funds was 5.8735 million yuan, accounting for 4.24% of the total transaction amount, while retail investors had a net outflow of 996,800 yuan, representing 0.72% of the total transaction amount [1][3] - The company held its 12th meeting of the 10th Board of Directors on January 9, 2026, where it approved the nomination of Wang Jianguo as a non-independent director candidate, pending shareholder meeting approval [1] Group 2 - Wandong Medical will hold its first extraordinary general meeting of 2026 on January 26, 2026, to vote on the election of non-independent director candidate Wang Jianguo, with a record date of January 20, 2026 [2] - The company announced a "Quality Improvement and Efficiency Enhancement Return" action plan, focusing on enhancing operational quality, promoting innovation in medical imaging equipment, and maintaining shareholder interests through cash dividends [2] - The action plan includes commitments to strengthen investor communication, improve transparency in information disclosure, and revise the company’s articles of association, including the cancellation of the supervisory board [2]
股市必读:万东医疗(600055)1月9日主力资金净流入587.35万元,占总成交额4.24%